This inventor holds 3 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: The Innovative Contributions of Carmel Horgan
Introduction
Carmel Horgan is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of biomedical research, particularly in the study of osteopontin and its interactions with integrins. With a total of 3 patents to her name, Horgan's work has implications for therapeutic approaches to inflammatory diseases.
Latest Patents
Carmel Horgan's latest patents focus on methods of screening for inhibitors of osteopontin. Specifically, her research identifies amino acids 136 to 142 and 162 to 168 of human osteopontin as critical sites for interaction with α4 integrins. Products that can disrupt these interactions are considered valuable in the treatment of various inflammatory diseases.
Career Highlights
Throughout her career, Horgan has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her experience in these organizations has allowed her to contribute to significant advancements in medical research and drug development.
Collaborations
Carmel Horgan has collaborated with esteemed colleagues such as Simon Thomas Barry and Steven Ludbrook. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Carmel Horgan's innovative work in the field of osteopontin research exemplifies her dedication to advancing medical science. Her patents and collaborations highlight her significant contributions to therapeutic development for inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile